Thanks, @Austin.
I don't expect people like Alex to look at a complicated calculation that concludes "and therefore gene drives are 10x as effective as anti-mosquito drones" and think "okay, so I should drop what I'm doing and work on gene drives"
My Fermi estimate compared Alex's project with Against Malaria Foundation's (AMF's) bednests in DRC, not with gene drives. I am also not expecting Alex to drop the project, but I would appreciate it if @ScottAlexander / @acx-grants could explain their rationale for funding this project. Is the project being funded because it could realistically be funded by GiveWell in the future, i.e. because it could be at least 10 times as cost-effective as donating to people in extreme poverty via GiveDirectly?
Alex might just not believe the calculations -- for plausible reasons! He has a bunch more insight into what's good about drones than an outside observer.
Note my conclusion of AMF's bednets distribution in DRC being 15.3 times as cost-effective as anti-mosquito drones relied on Alex's own calculations. Are you suggesting Alex does not believe in his own calculations, or that my comparison is flawed in some way? I guess the latter, but then it would be nice if you could be more specific. I basically just relied on GiveWell's numbers, which are usually considered quite trustworthy. It is also the case that the real cost-effectiveness tends to be much lower than what is suggested by preliminary results produced by the people proposing the project. One has to control for a thinker's big idea (https://forum.effectivealtruism.org/posts/GW3cxBurTNKHs352S/controlling-for-a-thinker-s-big-idea). So, even if Alex's own calculations are uncertain, I think they will tend to overestimate the cost-effectiveness of the project.
I do think anti-mosquito drones have a realistic chance (eg >1%) of being sufficiently cost effective to be part of the fight against malaria
What do you think is the probability of GiveWell funding Alex's anti-mosquito drones this year? I guess it is around 1 %, and this seems to low to be worth funding. One could contribute to the seed funding of the charities incubated by Charity Entrepreneurship (https://www.givingwhatwecan.org/charities/charity-entrepreneurship-incubated-charities), and I am much more optimistic about their chances of becoming at least as cost-effective as GiveWell's interventions. Charity Entrepreneurship is quite aligned with maximising impact, and their founders go through a very selective process (e.g. I am pretty confident they would understand the concept of marginal cost-effectiveness).
His current set of skills sets him up really well for doing this particular project; founder-market fit is super important in making projects go well
I agree. However, I am thinking a project going well is a necessary rather than sufficient condition for funding it. If a project has the main goal of saving/improving lives, it (or a future iteration of it) still has to do it more cheaply than the best alternatives (like bednets). To illustrate, I am quite confident GiveDirectly makes unconditional cash transfers go well, but I think people wanting to save/improve lives as much as possible had better donate to GiveWell's funds, which fund projects at least 10 times as cost-effective as GiveDirectly.
I think you're underrating "because it sounds cool", I guess. To shore this up a bit more, sounding cool is an important factor in getting buzz, being able to raise further funding, get stakeholders to agree to participate, etc.
As above, I agree these considerations are relevant, but they are not enough. PlayPump sounded like a cool cost-effective way of supplying water to people in low income countries, and it attracted lots of funding on this basis, but it turned out to be way less cost-effective that the best alternatives (https://forum.effectivealtruism.org/topics/playpump). I believe greater scrutiny would have revealed this earlier.
I think the general approach of analyzing cost effectiveness just doesn't really make sense for projects at this stage, or is at best one of many different lens. Cost effectieness is a reasonable sanity check, maybe; other than that, I'd look to other signals like founder quality and project velocity
I think cost-effectiveness analyses make sense for early stage projects if they are easy to produce, and I suppose it was quite easy for Alex to get the estimate of 50 $/person/year in his 1st comment in this thread. In addition, I would say it would be worth it to spend more time coming up with a better estimate, as this would very much inform the requirements of the drone. It may be that the requirements for the drones to save lives as cost-effectively as GiveWell's interventions are very unrealistic (e.g. the cost per drone would have to be unreasonably low), which may prompt rethinking or dropping the project.
I agree other considerations besides cost-effectiveness are also relevant, but I feel like you are underweighting it because it seems quite quantifiable in the case of Alex's project (as Alex nicely illustrated). Elie Hassenfeld, who is the CEO of GiveWell (whose evaluations are considered the gold-standard in global health and development), said (https://podcast.clearerthinking.org/episode/096/elie-hassenfeld-why-it-s-so-hard-to-have-confidence-that-charities-are-doing-good/):
GiveWell cost- effectiveness estimates are not the only input into our decisions to fund malaria programs and deworming programs, there are some other factors, but they're certainly 80% plus of the case.
GiveWell said (https://forum.effectivealtruism.org/posts/CDt5ShpdABZRn8Tvi/my-quick-thoughts-on-donating-to-ea-funds-global-health-and?commentId=CXspdihsLLSepbyjC):
The numerical cost-effectiveness estimate in the spreadsheet is nearly always the most important factor in our recommendations, but not the only factor. That is, we don’t solely rely on our spreadsheet-based analysis of cost-effectiveness when making grants.
I assume I am also less optimistic than you about Alex. I get the impression Alex may want to go ahead with the project even if he was certain it would be less cost-effective than GiveWell's interventions, and his project absorbed funding which would otherwise go to GiveWell's interventions, which I think would be bad. I am also not sure Alex understands the concept of marginal cost-effectiveness based on his 2nd comment in this thread.